Gary Nabel
Director/Miembro de la Junta en SIGA TECHNOLOGIES, INC. .
Fortuna: 25 M $ al 30/04/2024
Cargos activos de Gary Nabel
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SIGA TECHNOLOGIES, INC. | Director/Miembro de la Junta | 15/06/2021 | - |
| Independent Dir/Board Member | 15/06/2021 | - | |
| OPKO HEALTH, INC. | Director/Miembro de la Junta | 09/05/2022 | - |
| Corporate Officer/Principal | 09/05/2022 | - | |
| CANDEL THERAPEUTICS, INC. | Director/Miembro de la Junta | 08/08/2022 | - |
| Independent Dir/Board Member | 08/08/2022 | - |
Historial de carrera de Gary Nabel
Antiguos cargos conocidos de Gary Nabel.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Modex Therapeutics, Inc.
 Modex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of OPKO Health, Inc., ModeX Therapeutics, Inc. is a biotechnology research company focused on developing multi-specific immune therapies for cancer and infectious diseases. The company is based in Natick, MA. The company was founded in 2020 by Elias A. Zerhouni, Gary J. Nabel, Alexis A. Borisy. ModeX Therapeutics was acquired by OPKO Health, Inc. on May 09, 2022 for $300 million. | Director Ejecutivo | 01/11/2020 | 01/05/2022 |
| Fundador | 01/11/2020 | 01/05/2022 | |
| Presidente | 01/11/2020 | 01/05/2022 | |
| SANOFI | Director Técnico/Científico/I+D | 16/11/2012 | 01/11/2020 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01/01/1999 | 01/01/2012 |
Keystone Symposia
 Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Presidente | - | - |
Formación de Gary Nabel.
| Harvard University | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 9 |
| Francia | 2 |
Operativa
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| SIGA TECHNOLOGIES, INC. | Health Technology |
| SANOFI | Health Technology |
| OPKO HEALTH, INC. | Health Services |
| CANDEL THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Keystone Symposia
Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Commercial Services |
Modex Therapeutics, Inc.
Modex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of OPKO Health, Inc., ModeX Therapeutics, Inc. is a biotechnology research company focused on developing multi-specific immune therapies for cancer and infectious diseases. The company is based in Natick, MA. The company was founded in 2020 by Elias A. Zerhouni, Gary J. Nabel, Alexis A. Borisy. ModeX Therapeutics was acquired by OPKO Health, Inc. on May 09, 2022 for $300 million. | Commercial Services |
- Bolsa de valores
- Insiders
- Gary Nabel
- Experiencia